‘Many failures’: FDA whistleblower spills on DEI and bad practices during Biden administration Fox News Digital spoke to former FDA official David Oliveira about the FDA’s tobacco chief ...

To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...

U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as recent layoffs have reportedly had ...

Layoffs at the Food and Drug Administration are expected to reduce the FDA's workforce by 20%. Susan Mayne, former director of the Center for Food Safety and Applied Nutrition at the FDA ...

Minnesota is home to hundreds of medical device companies that can't sell new technologies or produce revenue without FDA review. A federal official did not answer questions about the cause of the ...

On March 26, 2025, the Company announced that the U.S. Food and Drug Administration (FDA) issued an Approvable Letter regarding the Company's Pre-Market Approval (PMA) application for the Genio ...

In this first installment of "Exit Interviews," MedPage Today editor-in-chief Jeremy Faust, MD, sits down with two-time FDA Commissioner Robert Califf, MD, to discuss what it was like running a ...

The FDA has updated the definition of "healthy" on food labels to better reflect current nutritional science. Foods must now meet criteria for beneficial nutrients and limits on added sugars ...

As President Donald Trump’s massive overhaul of federal agencies continues, several former FDA officials spoke about the potential ramifications for drug reviews and provided a look inside curre ...

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. HealthDay News — The US Food and Drug Administration (FDA) has delayed the full ...

The FDA has ordered Raptim Research, a clinical research company based in India, to redo several studies after the agency found evidence of data falsification. The FDA’s investigation ...

The U.S. Food and Drug Administration (FDA) has notified an unspecified number of drug companies that data from all in vitro bioequivalence studies conducted by the Navi Mumbai-based contract ...